Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

Best-of-Day Video Highlights

Highlights from the recent SNO Meeting and a complete list of abstracts

Read Full Story

Call for Abstracts - SNO Pediatric Neuro-Oncology Basic and Translational Research Conference

Submission Deadline - Friday, January 20, 2017

Read Full Story

Career Lounge at SNO

Thank you to all employers and applicants

Read Full Story
View All News

February
19

CNIO Frontiers Meeting - Primary and Secondary Brain Tumors

Read Full Story

February
24

10th Annual International Symposium on Stereotactic Body Radiation Therapy and Stereotactic Radiosurgery

Read Full Story

March
02

Twenty-Third Annual Blood-Brain Barrier Consortium Meeting

Read Full Story

WFNOS Magazine

 

The Society for Neuro-Oncology (SNO)
and the European Association of Neuro-Oncology (EANO)
have the pleasure to announce the publication of the first issue of the
World Federation of Neuro-Oncology Societies (WFNOS) Magazine

This new magazine is a transition from the EANO magazine and pursues the mission
to become a central platform for communication for all those interested in neuro-oncology,
including professionals involved in the diagnosis and care of brain tumor patients across the world.

 

 WFNO_Magazine.png

 

Table of Contents

  • NSCLC Cell Adhesion to and Transmigration through Brain Endothelium in Brain Metastasis
  • Prevention of Brain Metastasis by Inhibition of Angiogenesis?
  • Glioblastoma: Example of Translational Research in Radiotherapy and Radiobiology
  • Development of a Questionnaire to Measure Instrumental Activities of Daily Living (IADL) in Patients with Brain Tumors
  • A pro/con debate on the first-line treatment of patients with high-grade gliomas: An interview with Roger Stupp and Michael Prados
  • Indian Society of Neuro-Oncology: Challenges and Opportunities
  • Nurses Corner
  • Brain Tumor Patient Advocacy—Who Needs It?
  • Targeting IDH1R132H in WHO grade III and IV IDH1R132H-mutated gliomas by a peptide vaccine: a first-in-man phase I safety, tolerability, and immunogenicity multicenter trial (NOA-16)
  • Hotspots in Neuro-Oncology 2016

To view the entire Volume 1 (2016) Issue 1, please click here (pdf)